Visceral pathology of acute systemic injury in newborn mice on the onset of Coxsackie virus infection

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 890-904

  Wang, Lulu ^a   Dong, Changyuan ^a   Chen, Dong E ^a   Song, Zhen ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Acute neonatal systemic disease; Coxsackievirus B; Mutation sites; Pathological diversity

Indexed keywords

VIRUS RNA;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; COXSACKIE VIRUS INFECTION; DISEASE MODEL; ENTEROVIRUS; FEMALE; GENETICS; HEART DISEASE; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; LUNG DISEASE; MALE; MOLECULAR GENETICS; MOUSE; NEWBORN; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TUNEL ASSAY; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS; FEMALE; HEART DISEASES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER DISEASES; LUNG DISEASES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

EID: 84899534448     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5: 1019-1032.
2. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States 1983-2003. Pediatr Infect Dis J 2006; 25: 889-893.
3. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Centers for Disease Control and Prevention: Enterovirus surveillance-United States, 1970-2005. MMWR Surveill Summ 2006; 55: 1-20.
4. Kibrick S. Viral infections of the fetus and newborn. Edited by Pollard M. Perspectives in virology II. Minneapolis: Burgess Publishing Co, 1961, pp: 140-157.
5. Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008; 323: 275-292.
6. Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB, Pham-Mitchell N, Campbell IL, Whitton JL. Viral per sistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 2009; 83: 9356-9369.
7. Lin TY, Kao HT, Hsieh SH, Huang YC, Chiu CH, Chou YH, Yang PH, Lin RI, Tsao KC, Hsu KH, Chang LY. Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J 2003; 22: 889-894.
8. Flewett TH. Histological study of two cases of Coxsackie B virus pneumonia in children. J Clin Pathol 1965; 18: 743-746.
9. Tracy S, Gauntt C. Group B Coxsackievirus Virulence. Curr Top Microbiol Immunol 2008; 323: 49-63.
10. Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van Kuppeveld F, Melchers WJ, Galama JM. Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 2005; 86: 3271-3280.
11. Modlin JF. Perinatal echovirus and group B coxsackievirus infections. Clin Perinatol 1988; 15: 233-246.
12. Romero JR. Pediatric Group B Coxsackievirus Infections. Edited by Tracy S, Oberste MS, Drescher KM. Group B Coxsackieviruses. Heidelberg: Springer-Verlag, 2008, pp: 223-240.
13. Abzug MJ. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001; 20: 758-763.
14. Eckert HL, Portnoy B, Salvatore MA, Ressler R. Group B Coxsackie virus infection in infants with acute lower respiratory disease. Pediatrics 1967; 39: 526-531.
15. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368: 312-322.
16. Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. J Infect Dis 2012; 205: 491-497.
17. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003; 163: 1379-1393.
18. Minkowitz S and Berkovich S. Hepatitis produced by coxsackievirus B1 in adult mice. Arch Pathol 1970; 89: 427-433.
19. Cheng LL, Ng PC, Chan PK, Wong HL, Cheng FW, Tang JW. Probable Intrafamilial Transmission of Coxsackievirus B3 With Vertical Transmission, Severe Early-Onset Neonatal Hepatitis, and Prolonged Viral RNA Shedding. Pediatrics 2006; 118: 929-933.
20. Porres ER, Werthammer J, Moss N, Bernstein JM, Belshe RB. Fatal coxsackievirus B4 infection in a neonate. South Med J 1985; 78: 1254-1256.
21. Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 2007; 41: 118-122.
22. Vargová A, Bopegamage S, Borsanyiová M, Petrovicová A, Benkovicová M. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route. Acta Virol 2003; 47: 253-257.
23. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. J Virol Methods 1938; 27: 493-497.
24. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999; 41: 95-98.
25. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195-201.
26. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003; 31: 3381-3385.
27. Guex N, Peitsc MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modelling. Electrophoresis 1997; 18: 2714-2723.
28. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
29. Rosner B. Fundamentals of Biostatistics. 5th ed. In: Rosner B, eds. Pacific Grove: Duxbury, 2000, pp: 555.
30. Diegert C, Diegert KV. Note on Inversion of Casagrande-Pike-Smith Approximate Sample-Size Formula for Fisher-Irwin Test on 2×2 Tables. Biometrics 1981; 37: 595.
31. Fleiss JL, Tytun A, Ury HK. A Simple Approximation for Calculating Sample Sizes for Comparing Independent Proportions. Biometrics 1980; 36: 343-346.
32. Walters DE. In defense of the arc sine approximation. Journal of the Royal Statistical Society 1979; 28: 219-222.
33. Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 1993; 12: 820-824.
34. Lake AM, Lauer BA, Clark JC, Wesenberg RL, McIntosh K. Enterovirus infections in neonates. J Pediatr 1976; 89: 787-791.
35. Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001; 11: 355-368.
36. Abelmann WH. Virus and the heart. Circulation 1971; 44: 950-956.
37. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Yazaki Y. Evidence of perforin-mediated cardiac myocyte injury in acute murine myocarditis caused by Coxsackie virus B3. J Pathol 1993; 170: 53-58.
38. Verboon-Maciolek MA, Krediet TG, van Loon AM, Kaan J, Galama JM, Gerards LJ, Fleer A. Epidemiological survey of neonatal non-polio enterovirus infection in the Netherlands. J Med Virol 2002; 66: 241-245.
39. Grist NR, Bell EJ, Assaad F. Enteroviruses in human disease. Prog Med Virol 1978; 24: 114-157.
40. Whitton JL. Immunopathology during coxsackievirus infection. Springer Semin Immunopathol 2002; 24: 201-213.
41. Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal Med 2009; 14: 222-227.
42. Wang SM, Liu CC, Yang YJ, Yang HB, Lin CH, Wang JR. Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J Infect 1998; 37: 270-273.
43. Clavell M, Barkemeyer B, Martinez B, Craver R, Correa H, Gohd R, Schmidt-Sommerfeld E. Severe hepatitis in a newborn with coxsackievirus B5 infection. Clin Pediatr (Phila) 1999; 38: 739-741.
44. Toshima H, Ohkita Y, Shingu M. Clinical features of acute coxsackie B viral myocarditis. Jpn Circ J 1979; 43: 441-444.
45. Read RB, Ede RJ, Morgan-Capner P, Moscoso G, Portmann B, Williams R. Myocarditis and fulminant hepatic failure from coxsackievirus B infection. Postgrad Med J 1985; 61: 749-752.
46. Hofmann H, Heinz F, Stary A. Aetiological studies on viral pneumonia (author's transl). Wien Klin Wochenschr 1976; 88: 412-415.
47. Couch RB, Douglas RG Jr, Lindgren KM, Gerone PJ, Knight V. Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol 1970; 91: 78-86.
48. McGeady ML, Siak JS, Crowell RL. Survival of coxsackievirus B3 under diverse environmental conditions. Appl Environ Microbiol 1979; 37: 972-977.
49. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol 1995; 69: 4607-4618.
50. Bailey JM, Tapprich WE. Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis. J Virol 2007; 81: 650-668.
51. Baxter NJ, Roetzer A, Liebig HD, Sedelnikova SE, Hounslow AM, Skern T, Waltho JP. Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease. J Virol 2006; 80: 1451-1462.